¼¼°èÀÇ ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀå : ¼­ºñ½ºº°, ´Ü°èº°, ÀûÀÀÁõº°, ÃÖÁ¾ ¿ëµµº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Clinical Trial Central Laboratory Services Market, By Service, By Phase, By Indication, By End Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1756435
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 395 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,474,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,401,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,778,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀå ±Ô¸ð´Â 2024³â 41¾ï 2,312¸¸ ´Þ·¯·Î 2024³âºÎÅÍ 2032³â±îÁö CAGR 9.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀå ¿ªÇÐ

È¿À²ÀûÀÎ ÀÓ»ó½ÃÇè °ü¸®¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

ÀÓ»ó½ÃÇèÀÇ º¹À⼺ ¹× ±Ô¸ð È®´ë·Î ÀÎÇØ ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Áß¾ÓÁýÁßÇü ½ÇÇè½ÇÀº ¿©·¯ ÀÓ»ó½ÃÇè ±â°ü¿¡¼­ Ç¥ÁØÈ­µÈ °Ë»ç¿Í ÀϰüµÈ µ¥ÀÌÅÍ Ç°ÁúÀ» Á¦°øÇÏ¿© ÆíÂ÷¿Í ¿À·ù¸¦ ÁÙÀÔ´Ï´Ù. ÀÌ·¯ÇÑ È¿À²¼ºÀº ÀÇ»ç°áÁ¤°ú ÀǾàǰ ½ÂÀÎ ÇÁ·Î¼¼½º¸¦ °¡¼ÓÈ­ÇÕ´Ï´Ù. ¶ÇÇÑ, ÀǾàǰ Çõ½Å°ú ¸ÂÃãÇü ÀÇ·á¿¡ ÈûÀÔ¾î Àü ¼¼°èÀûÀ¸·Î ÀÓ»ó½ÃÇèÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½Å·ÚÇÒ ¼ö ÀÖ´Â Áß¾ÓÁýÁßÇü °Ë»ç ½Ã¼³ÀÌ ÇÊ¿äÇÕ´Ï´Ù. °­È­µÈ µ¥ÀÌÅÍ °ü¸® ±â´É°ú µðÁöÅÐ Ç÷§Æû°úÀÇ ÅëÇÕÀº ÀÓ»ó½ÃÇèÀÇ Á¤È®¼º°ú ±ÔÁ¤ Áؼö¸¦ ´õ¿í µÞ¹ÞħÇÕ´Ï´Ù. Àü¹ÝÀûÀ¸·Î ÀÌ·¯ÇÑ ¿äÀεéÀº ¼¾Æ®·² ·¦ ¼­ºñ½ºÀÇ Ã¤Åà Ȯ´ë¿¡ ±â¿©ÇÏ°í ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀå : ÁÖ¿ä ÀλçÀÌÆ®

´ç»çÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®¿¡ µû¸£¸é, ¼¼°è ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀåÀº 2024³âºÎÅÍ 2032³â±îÁö ¾à 9.6%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼­ºñ½ºº°·Î´Â 2023³â ¹ÙÀÌ¿À¸¶Ä¿ °Ë»ç ¼­ºñ½º°¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù.

ÀûÀÀÁõº°·Î º¸¸é 2023³â °¡Àå ¸¹Àº ¼öÀÍÀ» âÃâÇÑ ºÐ¾ß´Â Á¾¾ç ºÐ¾ß¿´½À´Ï´Ù.

Áö¿ªº°·Î´Â 2023³â ºÏ¹Ì°¡ °¡Àå ³ôÀº ¼öÀÍÀ» ¿Ã¸° Áö¿ªÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀå : ¼¼ºÐÈ­ ºÐ¼®

¼¼°è ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀåÀº ´ÙÀ½°ú °°Àº 5°¡Áö ¹üÁÖ·Î ºÐ·ùµË´Ï´Ù. ¼­ºñ½º, ´Ü°è, ÃÖÁ¾ ¿ëµµ, ÀûÀÀÁõ, Áö¿ªÀÔ´Ï´Ù.

¼­ºñ½ºº°·Î ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀåÀº ¸î °¡Áö ÁÖ¿ä Ä«Å×°í¸®·Î ºÐ·ùµË´Ï´Ù. ¹ÙÀÌ¿À¸¶Ä¿ °Ë»ç ¼­ºñ½º, ¹Ì»ý¹°ÇÐ ¼­ºñ½º, ÇØºÎº´¸®/Á¶Á÷ÇÐ, ¾àµ¿ÇÐ/¾à·ÂÇÐ(PK/PD), À¯Àüü/ºÐÀÚ °Ë»ç, °Ëü äÃë/ó¸®, ¹°·ù/°Ëü °ü¸®, µ¥ÀÌÅÍ °ü¸®/º¸°í, ±âŸ·Î ±¸ºÐµË´Ï´Ù. °¢ ¼­ºñ½º´Â Àü¹®ÀûÀÎ °Ë»ç, °Ëü ó¸®, µ¥ÀÌÅÍ ºÐ¼®À» ÅëÇØ ÀÓ»ó½ÃÇèÀ» Áö¿øÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ±× Áß¿¡¼­µµ ¹ÙÀÌ¿À¸¶Ä¿ °Ë»ç ¼­ºñ½º´Â ¸ÂÃãÀÇ·á¿Í Ç¥ÀûÄ¡·á¿¡ ÀÖ¾î ¸Å¿ì Áß¿äÇϱ⠶§¹®¿¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿À¸¶Ä¿´Â Áúº´ÀÇ ÁøÇà, Ä¡·á È¿°ú, ¾ÈÀü¼º Æò°¡¿¡ µµ¿òÀÌ µÇ±â ¶§¹®¿¡ ÀǾàǰ °³¹ß¿¡ ÇʼöÀûÀÔ´Ï´Ù. Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡¿Í ¹ÙÀÌ¿À¸¶Ä¿ Ž»öÀÇ ¹ßÀüÀº ÀÌ·¯ÇÑ ¼­ºñ½º¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖÀ¸¸ç, ¹ÙÀÌ¿À¸¶Ä¿ °Ë»ç´Â ÀÓ»ó½ÃÇè ¼¾ÅÍÀÇ ÁÖ¿ä ºÎ¹®À¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

ÀûÀÀÁõº°·Î ÀÓ»ó½ÃÇè¿ë Áß¾Ó°Ë»ç½Ç ¼­ºñ½º ½ÃÀåÀº Á¾¾ç, ½ÉÀåÁúȯ, ½Å°æÁúȯ, °¨¿°Áúȯ, ¸é¿ª ¹× ÀÚ°¡¸é¿ªÁúȯ, ±âŸ·Î ºÐ·ùµË´Ï´Ù. ÀÌµé ºÎ¹®Àº ÀÓ»ó½ÃÇè Áß Àü¹®ÀûÀÎ °Ë»ç Áö¿øÀÌ ÇÊ¿äÇÑ ´Ù¾çÇÑ Ä¡·á ¿µ¿ªÀ» ³ªÅ¸³À´Ï´Ù. ±× Áß¿¡¼­µµ Á¾¾ç ºÐ¾ß´Â Àü ¼¼°è ¾Ï ¹ßº´·üÀÌ ³ô°í, Ç¥ÀûÇ×¾ÏÁ¦ ¹× ¸é¿ªÄ¡·áÁ¦ÀÇ ±Þ¼ÓÇÑ ¹ßÀüÀ¸·Î ½ÃÀå °³Ã´¿¡ ÀÖ¾î À¯¸®ÇÑ À§Ä¡¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. º¹ÀâÇÑ Á¾¾çÇÐ ÀÓ»ó½ÃÇèÀº ±¤¹üÀ§ÇÑ ¹ÙÀÌ¿À¸¶Ä¿ °Ë»ç, À¯Àüü ºÐ¼®, ºó¹øÇÑ ¸ð´ÏÅ͸µÀÌ ¿ä±¸µÇ±â ¶§¹®¿¡ ¼¾Æ®·² ·¦ ¼­ºñ½º¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô½À´Ï´Ù. ¶ÇÇÑ, Á¾¾ç ¿¬±¸ ¹× ¸ÂÃã ÀÇ·á¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡´Â ÀÌ ºÐ¾ßÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇÏ¿© ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀåÀÇ ÁÖ¿ä ÀûÀÀÁõ ºÐ¾ß°¡ µÇ°í ÀÖ½À´Ï´Ù.

ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀå : Áö¿ªº° ºÐ¼®

Áö¿ªÀûÀ¸·Î ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀåÀº ºÏ¹Ì, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡ ºÐÆ÷µÇ¾î ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ºñÁî´Ï½º¸¦ °¡Á®¿À´Â ±¹°¡¸¦ ±â¹ÝÀ¸·Î ´õ ¼¼ºÐÈ­µË´Ï´Ù.

ºÏ¹Ì´Â ¼±ÁøÈ­µÈ ÀÇ·á ÀÎÇÁ¶ó, Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷ÀÇ °­·ÂÇÑ Á¸Àç°¨, ¸¹Àº ÀÓ»ó½ÃÇèÀ¸·Î ÀÎÇØ ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀåÀ» Áö¹èÇÏ´Â Áö¿ªÀÔ´Ï´Ù. ƯÈ÷ ¹Ì±¹Àº °­·ÂÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©, ¸·´ëÇÑ ¿¬±¸ ÀÚ±Ý, Çõ½ÅÀûÀÎ ±â¼ú äÅÃÀ¸·Î ½ÃÀåÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ª¿¡¼­´Â Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ º¹ÀâÇÑ ¹ÙÀÌ¿À¸¶Ä¿ ¹× À¯Àüü °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Çаè¿Í ¾÷°è °ü°èÀÚµéÀÇ Çù·ÂÀ¸·Î ÀÓ»ó½ÃÇè Ȱµ¿ÀÌ °­È­µÇ¸é¼­ ºÏ¹Ì´Â ÀǾàǰ °³¹ß¿¡¼­ ¼¾Æ®·² ·¦ ¼­ºñ½ºÀÇ Áß¿äÇÑ °ÅÁ¡ÀÌ µÇ°í ÀÖ½À´Ï´Ù.

À¯·´Àº ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀåÀ» Áö¹èÇÏ´Â ¶Ç ´Ù¸¥ ÁÖ¿ä Áö¿ªÀ¸·Î, µ¶ÀÏ, ¿µ±¹, ÇÁ¶û½º µî ¿©·¯ ±¹°¡¿¡¼­ Àß È®¸³µÈ Á¦¾à »ê¾÷°ú Áõ°¡ÇÏ´Â ÀÓ»ó½ÃÇè Ȱµ¿ÀÌ µÞ¹ÞħµÇ°í ÀÖ½À´Ï´Ù. À¯·´ÀǾàǰû(EMA)°ú °°Àº ±â°üÀÇ °­·ÂÇÑ ±ÔÁ¦ Áö¿øÀº ³ôÀº ¼öÁذú ±ÔÁ¤ Áؼö¸¦ º¸ÀåÇÏ°í ¼ö¸¹Àº ´Ù±¹Àû ÀÓ»ó½ÃÇèÀ» À¯Ä¡Çϰí ÀÖ½À´Ï´Ù. Èñ±ÍÁúȯ, Á¾¾çÇÐ, ¸ÂÃãÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁø °Íµµ Àü¹® °Ë»ç ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À¯·´ÀÇ °øµ¿ ¿¬±¸ ȯ°æ°ú ºÐÀÚ ¹× À¯Àüü °Ë»ç¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡´Â ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀåÀÇ ÁÖ¿ä Áö¿ªÀ¸·Î¼­ÀÇ ÀÔÁö¸¦ °­È­Çϰí ÀÖ½À´Ï´Ù.

ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀå : °æÀï »óȲ

ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀåÀº Labcorp, ICON plc, Eurofins Scientific, Thermo Fisher Scientific, Charles River Laboratories¿Í °°Àº ±âÁ¸ ±â¾÷µéÀÌ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÌµé ±â¾÷Àº ±¹Á¦ ÀÓ»ó½ÃÇè¿¡ ÇʼöÀûÀÎ Á¾ÇÕÀûÀÎ ÀÓ»ó °Ë»ç, µ¥ÀÌÅÍ °ü¸® ¹× ¹°·ù ¼Ö·ç¼ÇÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÷´Ü ±â¼ú, ¹ÙÀÌ¿À¸¶Ä¿ °Ë»ç, À¯Àüü ¼­ºñ½º¿¡ ´ëÇÑ ÁýÁßÀûÀÎ ÅõÀÚ´Â °æÀï ¿ìÀ§¿Í ±ÔÁ¦ Áؼö¸¦ À¯ÁöÇÏ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ½Å±Ô ÁøÀÔ ±â¾÷µéÀº µðÁöÅÐ µ¥ÀÌÅÍ ÅëÇÕ°ú ¿ø°Ý °Ëü °ü¸®ÀÇ ±â¼ú Çõ½ÅÀ» °­Á¶ÇÏ¸ç °æÀïÀ» ½ÉÈ­½Ã۰í ÀÖ½À´Ï´Ù. Áö¼ÓÀûÀÎ ¿¬±¸°³¹ß°ú Àü·«Àû ÆÄÆ®³Ê½ÊÀº ¼­ºñ½º È®ÀåÀ» ÃËÁøÇϰí, Àü ¼¼°è ÀÓ»ó½ÃÇèÀÇ Á¤È®¼º°ú È¿À²¼ºÀ» ³ôÀ̰í, ÀǾàǰ °³¹ß ÀÏÁ¤À» °³¼±ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½ºÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀå : »ê¾÷ ºÐ¼®

Á¦5Àå ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀå : ³ô¾ÆÁö´Â ÁöÁ¤ÇÐÀû ±äÀåÀÇ ¿µÇâ

Á¦6Àå ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀå »óȲ

Á¦7Àå ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀå : ¼­ºñ½ºº°

Á¦8Àå ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀå : ´Ü°èº°

Á¦9Àå ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀå : ÀûÀÀÁõº°

Á¦10Àå ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

Á¦11Àå ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ½ÃÀå : Áö¿ªº°

Á¦12Àå ÁÖ¿ä º¥´õ ºÐ¼® : ÀÓ»ó½ÃÇè¿ë ¼¾Æ®·² ·¦ ¼­ºñ½º ¾÷°è

Á¦13Àå AnalystViewÀÇ Àü¹æÀ§Àû ºÐ¼®

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Clinical Trial Central Laboratory Services Market size was valued at USD 4,123.12 Million in 2024, expanding at a CAGR of 9.6% from 2024 to 2032.

Clinical Trial Central Laboratory Services refer to specialized laboratories that provide standardized testing, sample analysis, and data management for clinical trials. These centralized labs ensure consistent, high-quality processing of biological samples such as blood, urine, or tissue from multiple trial sites. They play a crucial role in supporting drug development by delivering reliable, timely, and compliant laboratory results. Central labs facilitate protocol adherence, reduce variability, and enhance data integrity, helping sponsors and researchers make informed decisions during clinical studies. Their services often include biomarker testing, safety monitoring, and storage of specimens, all under strict regulatory guidelines.

Clinical Trial Central Laboratory Services Market- Market Dynamics

Increasing Demand for Efficient Clinical Trial Management

The growing complexity and scale of clinical trials are driving the demand for Clinical Trial Central Laboratory Services. Centralized labs offer standardized testing and consistent data quality across multiple trial sites, reducing variability and errors. This efficiency accelerates decision-making and regulatory approval processes. Additionally, the rise in global clinical trials, driven by pharmaceutical innovation and personalized medicine, necessitates reliable centralized testing facilities. Enhanced data management capabilities and integration with digital platforms further support trial accuracy and compliance. Overall, these factors contribute to the expanding adoption of central lab services, fueling market growth.

Clinical Trial Central Laboratory Services Market- Key Insights

According to our research analyst, the global Clinical Trial Central Laboratory Services Market is expected to develop at a CAGR of approximately 9.6% between 2024-2032.

Segmented by Service in 2023, the Biomarker Testing Services category dominated the market.

Based on Indication, the Oncology segment generated the most income in 2023.

Based onBased on region, in 2023, North America was the region with the highest revenue.

Clinical Trial Central Laboratory Services Market- Segmentation Analysis:

The global Clinical Trial Central Laboratory Services Market is divided into five categories: Service, Phase, End Use, Indication, and Region.

By service, the Clinical Trial Central Laboratory Services market is segmented into several key categories: Biomarker Testing Services, Microbiology Services, Anatomic Pathology/Histology, Pharmacokinetics/Pharmacodynamics (PK/PD), Genomic and Molecular Testing, Sample Collection and Processing, Logistics & Sample Management, Data Management & Reporting, and Others. Each service plays a vital role in supporting clinical trials through specialized testing, sample handling, and data analysis. Among these, Biomarker Testing Services dominate the market due to their critical importance in personalized medicine and targeted therapies. Biomarkers help in assessing disease progression, treatment efficacy, and safety, making them essential for drug development. The increasing focus on precision medicine and advancements in biomarker discovery drive high demand for these services, positioning Biomarker Testing as the leading segment in the clinical trial central laboratory landscape.

By indication, the Clinical Trial Central Laboratory Services market is segmented into Oncology, Cardiology, Neurology, Infectious Diseases, Immunology & Autoimmune Diseases, and Others. These segments represent the diverse therapeutic areas requiring specialized laboratory support during clinical trials. Among these, Oncology holds the dominant position in the market due to the high prevalence of cancer worldwide and the rapid development of targeted cancer therapies and immunotherapies. The complexity of oncology trials demands extensive biomarker testing, genomic analysis, and frequent monitoring, which drives significant reliance on central laboratory services. Moreover, increasing investment in oncology research and personalized medicine further fuels the growth of this segment, making it the leading indication area in the clinical trial central laboratory services market.

Clinical Trial Central Laboratory Services Market- Geographical Insights

Geographically, the Clinical Trial Central Laboratory Services Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America is a dominant region in the Clinical Trial Central Laboratory Services market, driven by its advanced healthcare infrastructure, strong presence of pharmaceutical and biotechnology companies, and a high volume of clinical trials. The U.S., in particular, leads due to robust regulatory frameworks, substantial research funding, and the adoption of innovative technologies. The region's focus on precision medicine and growing demand for complex biomarker and genomic testing further fuel market growth. Additionally, collaborations between academic institutions and industry players enhance clinical trial activities, making North America a critical hub for central laboratory services in drug development.

Europe is another key region dominating the Clinical Trial Central Laboratory Services market, supported by a well-established pharmaceutical industry and increasing clinical trial activities across countries like Germany, the U.K., and France. Strong regulatory support from agencies such as the European Medicines Agency (EMA) ensures high standards and compliance, attracting numerous multinational trials. The rising emphasis on rare diseases, oncology, and personalized medicine also contributes to the growing demand for specialized laboratory services. Moreover, Europe's collaborative research environment and growing investments in molecular and genomic testing bolster its position as a leading region in the central laboratory services market.

Clinical Trial Central Laboratory Services Market- Competitive Landscape:

The Clinical Trial Central Laboratory Services market is led by established players such as Labcorp, ICON plc, Eurofins Scientific, Thermo Fisher Scientific, and Charles River Laboratories. These companies offer comprehensive laboratory testing, data management, and logistics solutions critical to global clinical trials. Heavy investments in advanced technologies, biomarker testing, and genomic services help maintain competitive advantages and regulatory compliance. New entrants emphasize innovation in digital data integration and remote sample management, intensifying competition. Continuous R&D and strategic partnerships drive service expansion, enhancing accuracy and efficiency in clinical trials worldwide and improving drug development timelines.

Recent Developments:

In March 2025, Labcorp announced the expansion of its central laboratory services with the launch of a new genomics testing facility in the U.K., enhancing its capabilities in biomarker discovery and precision medicine.

In January 2024, ICON plc acquired a data management company to strengthen its digital clinical trial platforms, improving real-time data access and analytics for faster study outcomes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CLINICAL TRIAL CENTRAL LABORATORY SERVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL CLINICAL TRIAL CENTRAL LABORATORY SERVICES MARKET, BY SERVICE - MARKET ANALYSIS, 2019 - 2032

GLOBAL CLINICAL TRIAL CENTRAL LABORATORY SERVICES MARKET, BY PHASE - MARKET ANALYSIS, 2019 - 2032

GLOBAL CLINICAL TRIAL CENTRAL LABORATORY SERVICES MARKET, BY END USE - MARKET ANALYSIS, 2019 - 2032

GLOBAL CLINICAL TRIAL CENTRAL LABORATORY SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Clinical Trial Central Laboratory Services Market Overview

2. Executive Summary

3. Clinical Trial Central Laboratory Services Key Market Trends

4. Clinical Trial Central Laboratory Services Industry Study

5. Clinical Trial Central Laboratory Services Market: Impact of Escalating Geopolitical Tensions

6. Clinical Trial Central Laboratory Services Market Landscape

7. Clinical Trial Central Laboratory Services Market - By Service

8. Clinical Trial Central Laboratory Services Market - By Phase

9. Clinical Trial Central Laboratory Services Market - By Indication

10. Clinical Trial Central Laboratory Services Market - By End Use

11. Clinical Trial Central Laboratory Services Market- By Geography

12. Key Vendor Analysis- Clinical Trial Central Laboratory Services Industry

13. 360 Degree Analyst View

14. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â